Intestinal Parasitemia and HIV/AIDS Co-infections at Varying CD4+ T-cell Levels
Journal Title: HIV/AIDS Research and Treatment – Open Journal - Year 2017, Vol 4, Issue 1
Abstract
Background: Intestinal parasites, especially coccidian parasites, cause gastrointestinal symptoms such as severe diarrhoea which increases morbidity and mortality rates in people living with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), particularly in Sub-Saharan Africa. We examined the prevalence of intestinal parasites in people living with AIDS at different CD4+ T-cell levels. Method: Case-control studies were conducted over a four month period including a total of 672 participants, between the ages of 8 and 72 years. HIV screening and confirmatory tests were done. We examined stool samples by wet mount, followed by formol-ether concentration and staining with Modified Field’s and Ziehl Neelsen techniques. We also carried out fluorescenceactivated cell sorting (FACS) analyses to obtain their CD4+ T-cell levels. Results: The prevalence of intestinal parasites were significantly higher (25.2%) among HIV seropositives than HIV seronegative individuals (13.3%), (p less than 0.001) Coccidian parasites: Cystoisospora belli (formerly Isospora belli), Cryptosporidium and the round worm Strongyloides stercoralis infections were found exclusively in HIV seropositives. Cryptosporidium infections were more frequently observed in the rural cohort (p=0.039). C. belli, Cryptosporidium, Giardia lamblia and Strongyloides stercoralis infections were significantly higher in diarrhoeic stools. Microsporidia and Cystoisospora belli were found mostly in individuals with CD4+ T-cell levels of ≤200 cells/µL. Participants with CD4+ T-cell count of ≤50 cells/µL were associated with diarrhoea. Conclusion: The prevalence of opportunistic coccidian parasites remains high in HIV-infected individuals with low CD4+ T-cell counts. Routine diagnosis is recommended to ensure comprehensive care for HIV patients.
Authors and Affiliations
Kingsley Badu
Keywords
Related Articles
- EP ID EP555387
- DOI 10.17140/HARTOJ-4-126
- Views 119
- Downloads 0
Why Novel Nanoparticle-based Delivery Platforms Hold Key for HIV/AIDS Treatment and Prevention?
The administration of highly active antiretroviral therapy (HAART) to HIV/AIDS patients has greatly reduced their morbidity and mortality. However, HAART regimens have myriad of limitations, which make it difficult to co...
Test and Start for People Living With HIV and Who Use Drugs in Low and Middle Income Countries
“Test and Start” implements the World Health Organization (WHO) recommendation of “treat all” by providing anti-retroviral treatment to persons newly diagnosed with HIV infection, at the time of their diagnosis. This HIV...
Homelessness, Mental Illness, Substance Abuse, and HIV: An Insidious Syndemic
Background: This cross-sectional study examined the effects of face-to-face (real) and virtual social support networks on the mental health status of Japanese HIV-positive males. Method: A nationwide online cross-section...
Preventable Deaths among HIV-Positive Patients: A Real-Life Perspective from a Teaching Hospital in Northern Mexico
Introduction Antiretroviral therapy (ART) in patients infected with human immunodeficiency virus (HIV) are more effective and better tolerated and for this reason the gap between life expectancy of an HIV-seropositive in...
HIV/AIDS and African American Women: Research Opportunities to Stem the Epidemic
HIV/AIDS in communities of color across the United States continues to be a devastating epidemic. The Centers for Disease Control (CDC) estimates the rate of new HIV infections to be higher among African American women c...